Isthmus Partners LLC Purchases Shares of 35,938 HCA Healthcare, Inc. (NYSE:HCA)

Isthmus Partners LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 35,938 shares of the company’s stock, valued at approximately $115,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. MFA Wealth Advisors LLC bought a new position in HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $28,000. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth about $27,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Royal Bank of Canada upped their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Finally, Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $359.89.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,844 shares of company stock worth $3,185,932. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 2.5 %

Shares of NYSE:HCA traded down $9.77 during midday trading on Friday, hitting $387.98. 2,248,803 shares of the stock were exchanged, compared to its average volume of 1,129,325. The business’s 50-day moving average price is $355.43 and its 200 day moving average price is $335.92. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $403.05. The stock has a market capitalization of $101.62 billion, a price-to-earnings ratio of 19.34, a P/E/G ratio of 1.52 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.29 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 22.5 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.